The FDA has approved Purdue Pharma’s Palladone…
In the wake of Merck’s decision to withdraw Vioxx because of unfavorable clinical trials data, Pfizer and Boehringer Ingelheim/Abbot Laboratories have stepped up efforts to
promote their respective rival COX-2 inhibitors, Celebrex and Mobic.
Novartis has heard pitches for its consumer and professional advertising business with a view toward consolidating its agency roster into 2-4 integrated shops.
The Accreditation Council for Continuing Medical Education (ACCME) ratified a revision of its Standards for Commercial Support that some fear could effectively prohibit physicians accepting honoraria from drug companies from conducting accredited CME.
Pfizer announced today that America’s uninsured can now obtain Pfizer prescription medicines at significant savings through more than 52,000 community pharmacies nationwide or via Pfizer’s mail order service. The savings are available through Pfizer’s new program, Pfizer Pfriends.
ArgiNox Pharmaceuticals, of Menlo Park, Ca named Giant Creative Strategy as the agency of record for their lead compound, tilarginine acetate. Tilarginine acetate is currently being studied in clinical trials for the treatment of cardiogenic shock. Giant will work with ArgiNox to develop an integrated scientific market preparation campaign, as well as naming and all…
Please login or register first to view this content.